[Pharmacology of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine, a new peripheral vasodilator agent].
D000818:Animals; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D001923:Brain Chemistry; D002415:Cats; D003331:Coronary Vessels / Q000187:drug effects; D004106:Dilatation / Q000187:drug effects; D004231:Diuresis / Q000187:drug effects; D004423:Ear / Q000187:drug effects; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D051379:Mice; D010100:Oxygen / Q000032:analysis / Q000097:blood; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors; D011817:Rabbits; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*; D014970:Xanthines / Q000494:pharmacology*
D014665:Vasodilator Agents; D014970:Xanthines; D010744:Phosphoric Monoester Hydrolases; D010100:Oxygen
Zur Pharmakologie des neuen peripheren Gefässdilatators 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin.